-
AstraZeneca to Invest $90-Mn in India over Next 5 Years
Biopharmaceutical firm AstraZeneca has revealed plans to invest $90-mn (around Rs. 590-crore) in India over the next five years. The announcement foll...
2018-04-25 17:25 -
Catalent Bolsters Drug Development Capabilities
Catalent Pharma Solutions has unveiled plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its Somerset...
2018-04-25 16:48 -
Grand River Expands Manufacturing Capacity
Grand River Aseptic Manufacturing, a parenteral contract development and manufacturing organization (CDMO), has made its second major equipment purcha...
2018-04-25 16:48 -
Heritage Pharma Makes Leadership Changes
Heritage Pharmaceuticals, an East Brunswick, NJ-based specialty generic pharmaceutical company, has appointed William Marth as president and chief exe...
2018-04-23 09:48 -
JLL and Water Street Acquire Triplefin
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, have acquired Triplefin. An ...
2018-04-23 09:48 -
WuXi AppTec Opens Laboratory Testing Facility in NJ
WuXi AppTec has opened its expanded Laboratory Testing Division (LTD) facility in New Jersey. The grand opening event was attended by state and local ...
2018-04-23 09:48 -
AMRI Renews NIH Contract
AMRI has won renewal of a 10-year contract worth up to $39.5 million with the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network ...
2018-04-23 09:48 -
BASF Joins Research Consortium on Personalised Nutrition
BASF has joined the ‘Personalized Nutrition & Health’ consortium founded by The Netherlands Organization for Applied Scientific Research (TNO) and W...
2018-04-20 11:08 -
India: Strides Shasun Gets USFDA Nod for Generic Ibuprofen Capsules
Strides Shasun said it has received approval from the US health regulator for generic Ibuprofen capsules, 200 mg, used for relieving pain.
2018-04-19 14:59 -
Cipla Launches Authorized Generic of Aloxi
Cipla USA, Inc. has announced the launch of an authorized generic version of Aloxi in the US under applicable agreements with Helsinn Healthcare SA, i...
2018-04-19 14:59
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- German Chemical Industry Outpu... Sep 15, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- ExxonMobil Eyes $1 Billion Pet... Sep 16, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products
Related Producers
